Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 102 entries
Sorted by: Best Match Show Resources per page
Relationship between Topoisomerase 2A RNA Expression and Recurrence after Adjuvant Chemotherapy for Breast Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research

Sparano JA, Goldstein LJ, Childs BH, Shak S, Brassard D, Badve S, Baehner FL, Bugarini R, Rowley S, Perez E, Shulman LN, Martino S, Davidson NE, Sledge GW, Gray R.
PMID: 19996222
Clin Cancer Res. 2009 Dec 15;15(24):7693-7700. doi: 10.1158/1078-0432.CCR-09-1450.

PURPOSE: To perform an exploratory analysis of the relationship between gene expression and recurrence in operable hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-normal breast cancer patients treated with adjuvant doxorubicin-containing chemotherapy. EXPERIMENTAL DESIGN: RNA was extracted...

Cite
Sparano JA, Goldstein LJ, Childs BH, et al. Relationship between Topoisomerase 2A RNA Expression and Recurrence after Adjuvant Chemotherapy for Breast Cancer. Clin Cancer Res. 2009;15(24):7693-7700doi: 10.1158/1078-0432.CCR-09-1450.
Sparano, J. A., Goldstein, L. J., Childs, B. H., Shak, S., Brassard, D., Badve, S., Baehner, F. L., Bugarini, R., Rowley, S., Perez, E., Shulman, L. N., Martino, S., Davidson, N. E., Sledge, G. W., & Gray, R. (2009). Relationship between Topoisomerase 2A RNA Expression and Recurrence after Adjuvant Chemotherapy for Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 15(24), 7693-7700. https://doi.org/10.1158/1078-0432.CCR-09-1450
Sparano, Joseph A, et al. "Relationship between Topoisomerase 2A RNA Expression and Recurrence after Adjuvant Chemotherapy for Breast Cancer." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 15,24 (2009): 7693-7700. doi: https://doi.org/10.1158/1078-0432.CCR-09-1450
Sparano JA, Goldstein LJ, Childs BH, Shak S, Brassard D, Badve S, Baehner FL, Bugarini R, Rowley S, Perez E, Shulman LN, Martino S, Davidson NE, Sledge GW, Gray R. Relationship between Topoisomerase 2A RNA Expression and Recurrence after Adjuvant Chemotherapy for Breast Cancer. Clin Cancer Res. 2009 Dec 15;15(24):7693-7700. doi: 10.1158/1078-0432.CCR-09-1450. PMID: 19996222; PMCID: PMC3396025.
Copy Download .nbib Format: NLM
Conducting Molecular Epidemiological Research in the Age of HIPAA: A Multi-Institutional Case-Control Study of Breast Cancer in African-American and European-American Women.

Journal of oncology

Ambrosone CB, Ciupak GL, Bandera EV, Jandorf L, Bovbjerg DH, Zirpoli G, Pawlish K, Godbold J, Furberg H, Fatone A, Valdimarsdottir H, Yao S, Li Y, Hwang H, Davis W, Roberts M, Sucheston L, Demissie K, Amend KL, Tartter P, Reilly J, Pace BW, Rohan T, Sparano J, Raptis G, Castaldi M, Estabrook A, Feldman S, Weltz C, Kemeny M.
PMID: 19865486
J Oncol. 2009;2009:871250. doi: 10.1155/2009/871250. Epub 2009 Oct 25.

Breast cancer in African-American (AA) women occurs at an earlier age than in European-American (EA) women and is more likely to have aggressive features associated with poorer prognosis, such as high-grade and negative estrogen receptor (ER) status. The mechanisms...

Cite
Ambrosone CB, Ciupak GL, Bandera EV, et al. Conducting Molecular Epidemiological Research in the Age of HIPAA: A Multi-Institutional Case-Control Study of Breast Cancer in African-American and European-American Women. J Oncol. 2009;2009:871250doi: 10.1155/2009/871250.
Ambrosone, C. B., Ciupak, G. L., Bandera, E. V., Jandorf, L., Bovbjerg, D. H., Zirpoli, G., Pawlish, K., Godbold, J., Furberg, H., Fatone, A., Valdimarsdottir, H., Yao, S., Li, Y., Hwang, H., Davis, W., Roberts, M., Sucheston, L., Demissie, K., Amend, K. L., Tartter, P., Reilly, J., Pace, B. W., Rohan, T., Sparano, J., Raptis, G., Castaldi, M., Estabrook, A., Feldman, S., Weltz, C., & Kemeny, M. (2009). Conducting Molecular Epidemiological Research in the Age of HIPAA: A Multi-Institutional Case-Control Study of Breast Cancer in African-American and European-American Women. Journal of oncology, 2009871250. https://doi.org/10.1155/2009/871250
Ambrosone, Christine B, et al. "Conducting Molecular Epidemiological Research in the Age of HIPAA: A Multi-Institutional Case-Control Study of Breast Cancer in African-American and European-American Women." Journal of oncology vol. 2009 (2009): 871250. doi: https://doi.org/10.1155/2009/871250
Ambrosone CB, Ciupak GL, Bandera EV, Jandorf L, Bovbjerg DH, Zirpoli G, Pawlish K, Godbold J, Furberg H, Fatone A, Valdimarsdottir H, Yao S, Li Y, Hwang H, Davis W, Roberts M, Sucheston L, Demissie K, Amend KL, Tartter P, Reilly J, Pace BW, Rohan T, Sparano J, Raptis G, Castaldi M, Estabrook A, Feldman S, Weltz C, Kemeny M. Conducting Molecular Epidemiological Research in the Age of HIPAA: A Multi-Institutional Case-Control Study of Breast Cancer in African-American and European-American Women. J Oncol. 2009;2009:871250. doi: 10.1155/2009/871250. Epub 2009 Oct 25. PMID: 19865486; PMCID: PMC2766507.
Copy Download .nbib Format: NLM
Pericarditis and pericardial effusion: management update.

Current treatment options in cardiovascular medicine

Sparano DM, Ward RP.
PMID: 21989746
Curr Treat Options Cardiovasc Med. 2011 Dec;13(6):543-55. doi: 10.1007/s11936-011-0151-8.

OPINION STATEMENT: Prompt recognition of the signs and symptoms of pericardial disease is critical so that appropriate treatments can be initiated. Acute pericarditis has a classical presentation, including symptoms, physical examination findings, and electrocardiography abnormalities. Early recognition of acute...

Cite
Sparano DM, Ward RP. Pericarditis and pericardial effusion: management update. Curr Treat Options Cardiovasc Med. 2011;13(6):543-55doi: 10.1007/s11936-011-0151-8.
Sparano, D. M., & Ward, R. P. (2011). Pericarditis and pericardial effusion: management update. Current treatment options in cardiovascular medicine, 13(6), 543-55. https://doi.org/10.1007/s11936-011-0151-8
Sparano, Dina M, and Ward, R Parker. "Pericarditis and pericardial effusion: management update." Current treatment options in cardiovascular medicine vol. 13,6 (2011): 543-55. doi: https://doi.org/10.1007/s11936-011-0151-8
Sparano DM, Ward RP. Pericarditis and pericardial effusion: management update. Curr Treat Options Cardiovasc Med. 2011 Dec;13(6):543-55. doi: 10.1007/s11936-011-0151-8. PMID: 21989746.
Copy Download .nbib Format: NLM
Isospin balls.

Physical review letters

Balachandran AP, Rai B, Sparano G, Srivastava AM.
PMID: 10035889
Phys Rev Lett. 1987 Aug 24;59(8):853-856. doi: 10.1103/PhysRevLett.59.853.

No abstract available.

Cite
Balachandran AP, Rai B, Sparano G, et al. Isospin balls. Phys Rev Lett. 1987;59(8):853-856doi: 10.1103/PhysRevLett.59.853.
Balachandran, A. P., Rai, B., Sparano, G., & Srivastava, A. M. (1987). Isospin balls. Physical review letters, 59(8), 853-856. https://doi.org/10.1103/PhysRevLett.59.853
Balachandran, et al. "Isospin balls." Physical review letters vol. 59,8 (1987): 853-856. doi: https://doi.org/10.1103/PhysRevLett.59.853
Balachandran AP, Rai B, Sparano G, Srivastava AM. Isospin balls. Phys Rev Lett. 1987 Aug 24;59(8):853-856. doi: 10.1103/PhysRevLett.59.853. PMID: 10035889.
Copy Download .nbib Format: NLM
Predictors of outcome in patients with de novo diagnosis of heart failure with reduced ejection fraction: Role of combined myocardial and lung Iodine-123 Meta-Iodobenzylguanidine imaging.

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology

Silverio A, Polito MV, Pace L, D'Auria F, Vitulano G, Scarano M, Citro R, Galasso G, Piscione F.
PMID: 30761483
J Nucl Cardiol. 2021 Feb;28(1):72-85. doi: 10.1007/s12350-019-01637-8. Epub 2019 Feb 13.

BACKGROUND: The predictors of outcome in patients with de novo diagnosis of heart failure (HF) with reduced ejection fraction (HFrEF) are poorly known.METHODS AND RESULTS: All consecutive HFrEF patients admitted between October 2012 and November 2017 with their first...

Cite
Silverio A, Polito MV, Pace L, et al. Predictors of outcome in patients with de novo diagnosis of heart failure with reduced ejection fraction: Role of combined myocardial and lung Iodine-123 Meta-Iodobenzylguanidine imaging. J Nucl Cardiol. 2019;28(1):72-85doi: 10.1007/s12350-019-01637-8.
Silverio, A., Polito, M. V., Pace, L., D'Auria, F., Vitulano, G., Scarano, M., Citro, R., Galasso, G., & Piscione, F. (2021). Predictors of outcome in patients with de novo diagnosis of heart failure with reduced ejection fraction: Role of combined myocardial and lung Iodine-123 Meta-Iodobenzylguanidine imaging. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 28(1), 72-85. https://doi.org/10.1007/s12350-019-01637-8
Silverio, Angelo, et al. "Predictors of outcome in patients with de novo diagnosis of heart failure with reduced ejection fraction: Role of combined myocardial and lung Iodine-123 Meta-Iodobenzylguanidine imaging." Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology vol. 28,1 (2021): 72-85. doi: https://doi.org/10.1007/s12350-019-01637-8
Silverio A, Polito MV, Pace L, D'Auria F, Vitulano G, Scarano M, Citro R, Galasso G, Piscione F. Predictors of outcome in patients with de novo diagnosis of heart failure with reduced ejection fraction: Role of combined myocardial and lung Iodine-123 Meta-Iodobenzylguanidine imaging. J Nucl Cardiol. 2021 Feb;28(1):72-85. doi: 10.1007/s12350-019-01637-8. Epub 2019 Feb 13. PMID: 30761483.
Copy Download .nbib Format: NLM
HHLA2 and TMIGD2: new immunotherapeutic targets of the B7 and CD28 families.

Oncoimmunology

Janakiram M, Chinai JM, Zhao A, Sparano JA, Zang X.
PMID: 26405587
Oncoimmunology. 2015 Apr 14;4(8):e1026534. doi: 10.1080/2162402X.2015.1026534. eCollection 2015 Aug.

We and others recently discovered HHLA2 as a new B7 family member and transmembrane and immunoglobulin domain containing 2 (TMIGD2) as one of its receptors. Based on a new study we propose that HHLA2 may represent a novel immunosuppressive...

Cite
Janakiram M, Chinai JM, Zhao A, et al. HHLA2 and TMIGD2: new immunotherapeutic targets of the B7 and CD28 families. Oncoimmunology. 2015;4(8):e1026534doi: 10.1080/2162402X.2015.1026534.
Janakiram, M., Chinai, J. M., Zhao, A., Sparano, J. A., & Zang, X. (2015). HHLA2 and TMIGD2: new immunotherapeutic targets of the B7 and CD28 families. Oncoimmunology, 4(8), e1026534. https://doi.org/10.1080/2162402X.2015.1026534
Janakiram, Murali, et al. "HHLA2 and TMIGD2: new immunotherapeutic targets of the B7 and CD28 families." Oncoimmunology vol. 4,8 (2015): e1026534. doi: https://doi.org/10.1080/2162402X.2015.1026534
Janakiram M, Chinai JM, Zhao A, Sparano JA, Zang X. HHLA2 and TMIGD2: new immunotherapeutic targets of the B7 and CD28 families. Oncoimmunology. 2015 Apr 14;4(8):e1026534. doi: 10.1080/2162402X.2015.1026534. eCollection 2015 Aug. PMID: 26405587; PMCID: PMC4570140.
Copy Download .nbib Format: NLM
RE: Advanced Breast Cancer Definitions by Staging System Examined in the Breast Cancer Surveillance Consortium.

Journal of the National Cancer Institute

Pisano ED, Gatsonis C, Sparano J, Troester MA, Yaffe M, Cole E, Schnall MD.
PMID: 33783531
J Natl Cancer Inst. 2021 Jul 01;113(7):938-939. doi: 10.1093/jnci/djab055.

No abstract available.

Cite
Pisano ED, Gatsonis C, Sparano J, et al. RE: Advanced Breast Cancer Definitions by Staging System Examined in the Breast Cancer Surveillance Consortium. J Natl Cancer Inst. 2021;113(7):938-939doi: 10.1093/jnci/djab055.
Pisano, E. D., Gatsonis, C., Sparano, J., Troester, M. A., Yaffe, M., Cole, E., & Schnall, M. D. (2021). RE: Advanced Breast Cancer Definitions by Staging System Examined in the Breast Cancer Surveillance Consortium. Journal of the National Cancer Institute, 113(7), 938-939. https://doi.org/10.1093/jnci/djab055
Pisano, Etta D, et al. "RE: Advanced Breast Cancer Definitions by Staging System Examined in the Breast Cancer Surveillance Consortium." Journal of the National Cancer Institute vol. 113,7 (2021): 938-939. doi: https://doi.org/10.1093/jnci/djab055
Pisano ED, Gatsonis C, Sparano J, Troester MA, Yaffe M, Cole E, Schnall MD. RE: Advanced Breast Cancer Definitions by Staging System Examined in the Breast Cancer Surveillance Consortium. J Natl Cancer Inst. 2021 Jul 01;113(7):938-939. doi: 10.1093/jnci/djab055. PMID: 33783531; PMCID: PMC8266380.
Copy Download .nbib Format: NLM
Immune Activation and Microbial Translocation as Prognostic Biomarkers for AIDS-Related Non-Hodgkin Lymphoma in the AMC-034 Study.

Clinical cancer research : an official journal of the American Association for Cancer Research

Martínez LE, Lensing S, Chang D, Magpantay LI, Mitsuyasu R, Ambinder RF, Sparano JA, Martínez-Maza O, Epeldegui M.
PMID: 34131000
Clin Cancer Res. 2021 Aug 15;27(16):4642-4651. doi: 10.1158/1078-0432.CCR-20-4167. Epub 2021 Jun 15.

PURPOSE: AIDS-related non-Hodgkin lymphoma (ARL) is the most common cancer in HIV-infected individuals in the United States and other countries in which HIV-positive persons have access to effective combination antiretroviral therapy (cART). Our prior work showed that pretreatment/postdiagnosis plasma...

Cite
Martínez LE, Lensing S, Chang D, et al. Immune Activation and Microbial Translocation as Prognostic Biomarkers for AIDS-Related Non-Hodgkin Lymphoma in the AMC-034 Study. Clin Cancer Res. 2021;27(16):4642-4651doi: 10.1158/1078-0432.CCR-20-4167.
Martínez, L. E., Lensing, S., Chang, D., Magpantay, L. I., Mitsuyasu, R., Ambinder, R. F., Sparano, J. A., Martínez-Maza, O., & Epeldegui, M. (2021). Immune Activation and Microbial Translocation as Prognostic Biomarkers for AIDS-Related Non-Hodgkin Lymphoma in the AMC-034 Study. Clinical cancer research : an official journal of the American Association for Cancer Research, 27(16), 4642-4651. https://doi.org/10.1158/1078-0432.CCR-20-4167
Martínez, Laura E, et al. "Immune Activation and Microbial Translocation as Prognostic Biomarkers for AIDS-Related Non-Hodgkin Lymphoma in the AMC-034 Study." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 27,16 (2021): 4642-4651. doi: https://doi.org/10.1158/1078-0432.CCR-20-4167
Martínez LE, Lensing S, Chang D, Magpantay LI, Mitsuyasu R, Ambinder RF, Sparano JA, Martínez-Maza O, Epeldegui M. Immune Activation and Microbial Translocation as Prognostic Biomarkers for AIDS-Related Non-Hodgkin Lymphoma in the AMC-034 Study. Clin Cancer Res. 2021 Aug 15;27(16):4642-4651. doi: 10.1158/1078-0432.CCR-20-4167. Epub 2021 Jun 15. PMID: 34131000; PMCID: PMC8364886.
Copy Download .nbib Format: NLM
Disability assessment using Google Maps.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Lavorgna L, Iaffaldano P, Abbadessa G, Lanzillo R, Esposito S, Ippolito D, Sparaco M, Cepparulo S, Lus G, Viterbo R, Clerico M, Trojsi F, Ragonese P, Borriello G, Signoriello E, Palladino R, Moccia M, Brigo F, Troiano M, Tedeschi G, Bonavita S.
PMID: 34142263
Neurol Sci. 2021 Jun 17; doi: 10.1007/s10072-021-05389-7. Epub 2021 Jun 17.

OBJECTIVES: To evaluate the concordance between Google Maps® application (GM®) and clinical practice measurements of ambulatory function (e.g., Ambulation Score (AS) and respective Expanded Disability Status Scale (EDSS)) in people with multiple sclerosis (pwMS).MATERIALS AND METHODS: This is a...

Cite
Lavorgna L, Iaffaldano P, Abbadessa G, et al. Disability assessment using Google Maps. Neurol Sci. 2021;doi: 10.1007/s10072-021-05389-7.
Lavorgna, L., Iaffaldano, P., Abbadessa, G., Lanzillo, R., Esposito, S., Ippolito, D., Sparaco, M., Cepparulo, S., Lus, G., Viterbo, R., Clerico, M., Trojsi, F., Ragonese, P., Borriello, G., Signoriello, E., Palladino, R., Moccia, M., Brigo, F., Troiano, M., Tedeschi, G., & Bonavita, S. (2021). Disability assessment using Google Maps. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, . https://doi.org/10.1007/s10072-021-05389-7
Lavorgna, Luigi, et al. "Disability assessment using Google Maps." Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology vol. (2021). doi: https://doi.org/10.1007/s10072-021-05389-7
Lavorgna L, Iaffaldano P, Abbadessa G, Lanzillo R, Esposito S, Ippolito D, Sparaco M, Cepparulo S, Lus G, Viterbo R, Clerico M, Trojsi F, Ragonese P, Borriello G, Signoriello E, Palladino R, Moccia M, Brigo F, Troiano M, Tedeschi G, Bonavita S. Disability assessment using Google Maps. Neurol Sci. 2021 Jun 17; doi: 10.1007/s10072-021-05389-7. Epub 2021 Jun 17. PMID: 34142263; PMCID: PMC8211455.
Copy Download .nbib Format: NLM
Correction to: Pain, quality of life, and religiosity in people with multiple sclerosis.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Sparaco M, Miele G, Abbadessa G, Ippolito D, Trojsi F, Lavorgna L, Bonavita S.
PMID: 34890003
Neurol Sci. 2021 Dec 10; doi: 10.1007/s10072-021-05814-x. Epub 2021 Dec 10.

No abstract available.

Cite
Sparaco M, Miele G, Abbadessa G, et al. Correction to: Pain, quality of life, and religiosity in people with multiple sclerosis. Neurol Sci. 2021;doi: 10.1007/s10072-021-05814-x.
Sparaco, M., Miele, G., Abbadessa, G., Ippolito, D., Trojsi, F., Lavorgna, L., & Bonavita, S. (2021). Correction to: Pain, quality of life, and religiosity in people with multiple sclerosis. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, . https://doi.org/10.1007/s10072-021-05814-x
Sparaco, Maddalena, et al. "Correction to: Pain, quality of life, and religiosity in people with multiple sclerosis." Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology vol. (2021). doi: https://doi.org/10.1007/s10072-021-05814-x
Sparaco M, Miele G, Abbadessa G, Ippolito D, Trojsi F, Lavorgna L, Bonavita S. Correction to: Pain, quality of life, and religiosity in people with multiple sclerosis. Neurol Sci. 2021 Dec 10; doi: 10.1007/s10072-021-05814-x. Epub 2021 Dec 10. PMID: 34890003.
Copy Download .nbib Format: NLM
Pain, quality of life, and religiosity in people with multiple sclerosis.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Sparaco M, Miele G, Abbadessa G, Ippolito D, Trojsi F, Lavorgna L, Bonavita S.
PMID: 34816315
Neurol Sci. 2021 Nov 23; doi: 10.1007/s10072-021-05759-1. Epub 2021 Nov 23.

PURPOSE: To investigate in multiple sclerosis (MS) patients, the relationship between pain and religiosity and to determine whether distinct dimensions of religiosity were associated with quality of life.METHODS: MS patients during clinical follow-up filled out the visual analogue scale...

Cite
Sparaco M, Miele G, Abbadessa G, et al. Pain, quality of life, and religiosity in people with multiple sclerosis. Neurol Sci. 2021;doi: 10.1007/s10072-021-05759-1.
Sparaco, M., Miele, G., Abbadessa, G., Ippolito, D., Trojsi, F., Lavorgna, L., & Bonavita, S. (2021). Pain, quality of life, and religiosity in people with multiple sclerosis. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, . https://doi.org/10.1007/s10072-021-05759-1
Sparaco, Maddalena, et al. "Pain, quality of life, and religiosity in people with multiple sclerosis." Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology vol. (2021). doi: https://doi.org/10.1007/s10072-021-05759-1
Sparaco M, Miele G, Abbadessa G, Ippolito D, Trojsi F, Lavorgna L, Bonavita S. Pain, quality of life, and religiosity in people with multiple sclerosis. Neurol Sci. 2021 Nov 23; doi: 10.1007/s10072-021-05759-1. Epub 2021 Nov 23. PMID: 34816315.
Copy Download .nbib Format: NLM
Minimal Extrathyroidal Extension in Predicting 1-Year Outcomes: A Longitudinal Multicenter Study of Low-to-Intermediate-Risk Papillary Thyroid Carcinoma (ITCO#4).

Thyroid : official journal of the American Thyroid Association

Forleo R, Grani G, Alfò M, Zilioli V, Giubbini R, Zatelli MC, Gagliardi I, Piovesan A, Ragni A, Morelli S, Puxeddu E, Pagano L, Deandrea M, Ceresini G, Torlontano M, Puligheddu B, Antonelli A, Centanni M, Fugazzola L, Spiazzi G, Monti S, Rossetto R, Monzani F, Tallini G, Crescenzi A, Sparano C, Bruno R, Repaci A, Tumino D, Pezzullo L, Lombardi CP, Ferraro Petrillo U, Filetti S, Durante C, Castagna MG.
PMID: 34541894
Thyroid. 2021 Sep 19; doi: 10.1089/thy.2021.0248. Epub 2021 Sep 19.

BACKGROUND: The role of minimal extrathyroidal extension (mETE) as a risk factor for persistent papillary thyroid carcinoma (PTC) is still debated. The aim of this study was to assess the clinical impact of mETE as a predictor of worse...

Cite
Forleo R, Grani G, Alfò M, et al. Minimal Extrathyroidal Extension in Predicting 1-Year Outcomes: A Longitudinal Multicenter Study of Low-to-Intermediate-Risk Papillary Thyroid Carcinoma (ITCO#4). Thyroid. 2021;doi: 10.1089/thy.2021.0248.
Forleo, R., Grani, G., Alfò, M., Zilioli, V., Giubbini, R., Zatelli, M. C., Gagliardi, I., Piovesan, A., Ragni, A., Morelli, S., Puxeddu, E., Pagano, L., Deandrea, M., Ceresini, G., Torlontano, M., Puligheddu, B., Antonelli, A., Centanni, M., Fugazzola, L., Spiazzi, G., Monti, S., Rossetto, R., Monzani, F., Tallini, G., Crescenzi, A., Sparano, C., Bruno, R., Repaci, A., Tumino, D., Pezzullo, L., Lombardi, C. P., Ferraro Petrillo, U., Filetti, S., Durante, C., & Castagna, M. G. (2021). Minimal Extrathyroidal Extension in Predicting 1-Year Outcomes: A Longitudinal Multicenter Study of Low-to-Intermediate-Risk Papillary Thyroid Carcinoma (ITCO#4). Thyroid : official journal of the American Thyroid Association, . https://doi.org/10.1089/thy.2021.0248
Forleo, Raffaella, et al. "Minimal Extrathyroidal Extension in Predicting 1-Year Outcomes: A Longitudinal Multicenter Study of Low-to-Intermediate-Risk Papillary Thyroid Carcinoma (ITCO#4)." Thyroid : official journal of the American Thyroid Association vol. (2021). doi: https://doi.org/10.1089/thy.2021.0248
Forleo R, Grani G, Alfò M, Zilioli V, Giubbini R, Zatelli MC, Gagliardi I, Piovesan A, Ragni A, Morelli S, Puxeddu E, Pagano L, Deandrea M, Ceresini G, Torlontano M, Puligheddu B, Antonelli A, Centanni M, Fugazzola L, Spiazzi G, Monti S, Rossetto R, Monzani F, Tallini G, Crescenzi A, Sparano C, Bruno R, Repaci A, Tumino D, Pezzullo L, Lombardi CP, Ferraro Petrillo U, Filetti S, Durante C, Castagna MG. Minimal Extrathyroidal Extension in Predicting 1-Year Outcomes: A Longitudinal Multicenter Study of Low-to-Intermediate-Risk Papillary Thyroid Carcinoma (ITCO#4). Thyroid. 2021 Sep 19; doi: 10.1089/thy.2021.0248. Epub 2021 Sep 19. PMID: 34541894.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 102 entries